Navigation Links
Fetal Lung Maturity

ProductsFetal Lung Maturity
Company ARUP Laboratories
Item Fetal Lung Maturity
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. FetalSAT™
2. Achondroplasia Mutation, Fetal
3. APT Test-Fetal Hemoglobin
4. Beta Globin Sequencing, Fetal
5. Chromosome Analysis, Fetal Blood
6. Cystic Fibrosis, Mutation Panel, Fetal
7. Factor V Leiden, Fetal
8. Fetal Fibronectin
9. Fetal Hemoglobin Determination for Fetomaternal Hemorrhage
10. Fetal Hemoglobin (Hemoglobin F)
11. Fetal Hemoglobin, Semi-Quantitative
... Transport beds feature folding head end and foot ... With the head end and foot end deck panels folded...ximately 67". This compact length makes storage, d...is feature is not available on Model 4748B, Basic ...
.... Patient dignity. A single solution., ,Hill-Rom ...d to provide added safety where its needed. Its lo...the caregiver and patient from injury, while impro... other TotalCare® beds, but its different the...
...able Prefilled 28%-100% FIO 2 1000ML 0.45% Sodium... unmatched performance and ease of use. You can ob...le from 28% to 100% FIO 2 . We offer a wide select...P; 0.45% sodium chloride inhalation, USP; and 0.9%...
...led 750ML Sterile H 2 O W/O Adapter., ,Filled...er systems feature a dual-purpose reservoir with a...r secure attachment of a humidifier adapter. The o...ate from reaching oxygen delivery tubing. An audib...
Medicine Products:
(Date:5/17/2008)... safe-limit price as guide for avoiding exposure ... Those inexpensive earrings you bought from a hip ...t bad for your ears and skin. , A new report fi... $50 by local San Francisco stores and artists con...lobes and repeated exposure can make treatment dif...
(Date:5/16/2008)...JoAnne,s Bed & Back; Merger Sets Up Healthy B...ail Chain, LORTON, Va., May 16 /PRNewswire/ -- He... home and workplace back wellness created an,ergon...ts of its rival,JoAnne,s Bed & Back. Healthy Back...evenues of $40million. JoAnne,s 16 mid-Atlantic st...
(Date:5/16/2008)...e in serum parathyroid hormone readings, study say... Low levels of vitamin D and high levels of a horm...e the risk of depression in older adults, accordin...d in the May issue of Archives of General Psychia... that vitamin D, depression and other psychiatric ...
(Date:5/16/2008)...ize the Importance of Oral and Overall Health, HA...tal insurer United,Concordia Dental is celebrating...l Health America and the British Dental Health Fou...o overall health. Beginning May 18,this year,s ev...t time,making it the largest independent internat...
Breaking Medicine News(10 mins):Health News:Cheaper Earrings More Likely to Contain Nickel 2Health News:Cheaper Earrings More Likely to Contain Nickel 3Health News:The Back Wars Come to a Close 2Health News:Low Vitamin D Tied to Depression in Older Adults 2Health News:United Concordia Dental Celebrates National Smile Month 2
...g investigated to find out how effectively it can ...g menopause. If successful, it might turn out to b...eplacement therapy instituted. It has been a prob...ecommend for patients who are not willing for horm...
...s had reported that men who report feeling nervous...ide than their counterparts who perceive themselve...ed // in the current issue of Journal of Epidemiol... are based on results from the Swedish Survey of L...
...hns Hopkins University School of Medicine had said...England Journal of Medicine that the disease calle... than people thought possible, to cause an outbre...nce of the recent outbreak in Arizona, US, as the ...
...ected leptospirosis and dengue in the densely popu... Mumbai over the pat three days has raised panic a...C) has been kept on high alert and has been forced...he area. The three suspected lepto victims died of...
Other Medicine News:Health News:Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts 2
(Date:5/16/2008)...s., May 16 /- BioVex Inc, a biotechno... oncology and infectious,disease, announced today ...rom its Phase II clinical trial of OncoVEX GM-CSF ...t the American Society of Clinical Oncology,(ASCO)...ry of the abstract,which describes the data as of ...
(Date:5/16/2008)...as Potential Biomarkers -- for Lung Cancer Diagnos... With Cancer of Unknown Primary ...ify Cancer Types With High Sensitivity and, Spec...tment of Cancer Results of microRNA Signature to ...uracy Exceeding 90% and Specificity of 99%, REHOV...
(Date:5/16/2008)...onstrates Statistically Significant Reductions in ...ons, - Abstract to be published in 2008 Proceeding... Clinical Oncology, SAN DIEGO, May 16 /PRNews...(Amex: ANX ) announced today that, in a registrat...strated a statistically significant reduction,in g...
(Date:5/15/2008)...zerland, May 15 /- Patients with brea...ommon cancers, can expect,further treatment advanc...(trastuzumab) following new data that is being pre...cology (ASCO) annual meeting in Chicago at,the end... the meeting which,is the premier event for cancer...
Breaking Medicine Technology:BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 4Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 5Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 6ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6Corgenix Announces FDA Clearance for IgG Anti AtherOx 28R 29 Test Kit 4509 1Corgenix Announces FDA Clearance for IgG Anti AtherOx 28R 29 Test Kit 4509 2Corgenix Announces FDA Clearance for IgG Anti AtherOx 28R 29 Test Kit 4509 3Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 1Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 2Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 3Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 4Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 5Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 6Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 7Method to deliver molecules within embryonic stem cells improves differentiation 4505 1Method to deliver molecules within embryonic stem cells improves differentiation 4505 2Method to deliver molecules within embryonic stem cells improves differentiation 4505 3PEMCOs Super Long Coffee Order Contest Taps First Winners 16440 1PEMCOs Super Long Coffee Order Contest Taps First Winners 16440 2
...; MENLO PARK, Calif.--(BUSINESS WIRE)--May,21, 200...XSP) notes,the publication of new clinical data re...R) (homoharringtonine). The paper "Targeted,therap...leukemias",by researchers Simona Soverini and coll...ologica Volume 92, pages 401-404) offers,insight i...
...E)--May 21, 2007 - Results from a new,study, prese...W),conference, showed that more than 99 percent of...ection who were treated,successfully with PEGASYS(... up to seven years later - validating the use of,t...ing to study,authors. Currently, the best indicato...
Other Medicine Technology:Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 2Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 3Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 2Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 3Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 4Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 5Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 6